117 related articles for article (PubMed ID: 28339471)
1. Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma.
Ma S; Yang J; Song C; Ge Z; Zhou J; Zhang G; Hu Z
PLoS One; 2017; 12(3):e0173700. PubMed ID: 28339471
[TBL] [Abstract][Full Text] [Related]
2. Expression quantitative trait loci in long non-coding RNA PAX8-AS1 are associated with decreased risk of cervical cancer.
Han J; Zhou W; Jia M; Wen J; Jiang J; Shi J; Zhang K; Ma H; Liu J; Ren J; Dai M; Hu Z; Hang D; Li N; Shen H
Mol Genet Genomics; 2016 Aug; 291(4):1743-8. PubMed ID: 27225188
[TBL] [Abstract][Full Text] [Related]
3. Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development.
Wen J; Liu Y; Liu J; Liu L; Song C; Han J; Zhu L; Wang C; Chen J; Zhai X; Shen H; Hu Z
Mol Carcinog; 2015 Nov; 54(11):1275-82. PubMed ID: 25110835
[TBL] [Abstract][Full Text] [Related]
4. Expression Quantitative Trait Loci for CARD8 Contributes to Risk of Two Infection-Related Cancers--Hepatocellular Carcinoma and Cervical Cancer.
Yin J; Wen J; Hang D; Han J; Jiang J; Song C; Liu Y; Liu J; Liu L; Zhu L; Chen J; Zhai X; Xie S; Hu Z; Shen H; Dai M; Li N
PLoS One; 2015; 10(7):e0132352. PubMed ID: 26147888
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism in lncRNA AC016683.6 and its interaction with smoking exposure on the susceptibility of lung cancer.
Li J; Li H; Lv X; Yang Z; Gao M; Bi Y; Zhang Z; Wang S; Cui Z; Zhou B; Yin Z
Cancer Cell Int; 2018; 18():91. PubMed ID: 29997452
[TBL] [Abstract][Full Text] [Related]
6. A potentially functional polymorphism in the promoter region of let-7 family is associated with survival of hepatocellular carcinoma.
Xie K; Liu J; Zhu L; Liu Y; Pan Y; Wen J; Ma H; Zhai X; Hu Z
Cancer Epidemiol; 2013 Dec; 37(6):998-1002. PubMed ID: 24103425
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.
Li Z; Li N; Li F; Zhou Z; Sang J; Jin Z; Liu H; Han Q; Lv Y; Liu Z
Oncotarget; 2016 May; 7(18):26168-80. PubMed ID: 27034168
[TBL] [Abstract][Full Text] [Related]
8. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
9. A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma.
Zhao B; Lu J; Yin J; Liu H; Guo X; Yang Y; Ge N; Zhu Y; Zhang H; Xing J
Liver Int; 2012 Oct; 32(9):1451-9. PubMed ID: 22809120
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
[TBL] [Abstract][Full Text] [Related]
11. miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.
Yu G; Xiao Q; Ma XP; Chen X; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Conran C; Zheng SL; Xu J; Yu L; Jiang DK
Tumour Biol; 2016 Jul; 37(7):8961-72. PubMed ID: 26753964
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of cell cycle pathway genes predict disease-free survival of hepatocellular carcinoma.
Liu S; Yang TB; Nan YL; Li AH; Pan DX; Xu Y; Li S; Li T; Zeng XY; Qiu XQ
Cancer Med; 2017 Jul; 6(7):1512-1522. PubMed ID: 28639733
[TBL] [Abstract][Full Text] [Related]
13. Association of twelve polymorphisms in three onco-lncRNA genes with hepatocellular cancer risk and prognosis: A case-control study.
Wang BG; Xu Q; Lv Z; Fang XX; Ding HX; Wen J; Yuan Y
World J Gastroenterol; 2018 Jun; 24(23):2482-2490. PubMed ID: 29930469
[TBL] [Abstract][Full Text] [Related]
14. A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy.
Tang Q; Zhao Y; Wang Y; Wei M
Med Oncol; 2014 Nov; 31(11):267. PubMed ID: 25270285
[TBL] [Abstract][Full Text] [Related]
15. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.
Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ
Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740
[TBL] [Abstract][Full Text] [Related]
16. The association of polymorphisms in lncRNA-
Yang ML; Huang Z; Wang Q; Chen HH; Ma SN; Wu R; Cai WS
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29511035
[TBL] [Abstract][Full Text] [Related]
17. Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma.
Liu PH; Hsia CY; Lee YH; Hsu CY; Huang YH; Su CW; Lee RC; Lin HC; Huo TI
J Surg Oncol; 2015 Mar; 111(4):404-9. PubMed ID: 25643842
[TBL] [Abstract][Full Text] [Related]
18. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants in glucose-6-phosphate isomerase gene as prognosis predictors in hepatocellular carcinoma.
Lyu Z; Chen Y; Guo X; Zhou F; Yan Z; Xing J; An J; Zhang H
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):698-704. PubMed ID: 27288297
[TBL] [Abstract][Full Text] [Related]
20. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
Zhang QX; Li SL; Yao YQ; Li TJ
Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
